Intravenous, Pulse-Loaded Clomipramine in Body Dysmorphic Disorder: Two Case Reports

CNS Spectrums

Volumn 1, Issue 2, 1996, Pages 54-57

  Pallanti, Stefano ^a   Koran, Lorrin M ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005177376     PISSN: 10928529     EISSN: 21656509     Source Type: Journal    
DOI: 10.1017/S1092852900002650     Document Type: Article

References (19)

1. American Psychiatric Association. Diagnostic and Statistical Manual ot Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Hollander, E, Phillips, KA. Body image and experience disorders: body dysmorphic and depersonalization disorders. In: Hollander, E, ed. Obsessive-Compulsive and Related Disorders. Washington, DC: American Psychiatric Press; 1993: 17–48.
3. Phillips, KA, McElroy, SL, Hudson, JI, Pope, HG Jr. Body dysmorphic disorder: an obsessive compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry. 1995; 56(suppl 4):41–51.
4. Simeon, D, Hollander, E, Stein, DJ, Cohen, L, Aronowitz, B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry. 1995; 152: 1207–1209.
5. Hollander, E, Wong, CM. Body dysmorphic disorder, pathological gambling, and sexual compulsions. J Clin Psychiatry. 1995; 56(suppl 4):7–12.
6. Phillips, KA, McElroy, SL, Keck, PE Jr, Pope, HG Jr, Hudson, JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry. 1993; 150: 302–308.
7. Phillips, KA, McElroy, SL. Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: theoretical and treatment implications. J Nerv Ment Dis. 1993; 181: 699–702.
8. Hollander, E, Liebowitz, MR, Winchel, R, Mumker, A, Klein, DF. Treatment of body dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry. 1989; 146: 768–770.
9. Brady, KT. Body dysmorphic disorder: the relationship to obsessive-compulsive disorder. J Nerv Ment Dis. 1990; 178: 538–540.
10. Phillips, KA, McElroy, SL, Keck, PE Jr, Pope, HG Jr, Hudson, JI. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull. 1994; 30: 179–186.
11. Hollander, E, Cohen, L, Simeon, D, Rosen, J, DeCaria, C, Stein, DJ. Fluvoxamine treatment of body dysmorphic disorder. J Clin Psychopharmacol. 1994; 14: 75–77.
12. Warneke, LB. The use of intravenous chlorimipramine in the treatment of obsessive compulsive disorder. Can J Psychiatry. 1984; 29: 135–141.
13. Warneke, LB. Intravenous chlorimipramine in the treatment of obsessional disorder in adolescence: case report. J Clin Psychiatry. 1985; 46: 100–103.
14. Warneke, LB. Intravenous chlorimipramine therapy in obsessive-compulsive disorder. Can J Psychiatry. 1989; 34: 853–859.
15. Fallon, BA, Campeas, R, Schneier, FR, et al, Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. J Neuro-psychiatry. 1992; 4: 70–75.
16. Koran, LM, Faravelli, C, Pallanti, S. Intravenous clomipramine for obsessive-compulsive disorder. J Clin Psychopharmacol. 1994; 14: 216–218.
17. Sallee, FR, Pollock, BG, Perel, JM, Ryan, ND, Stiller, RL. Intravenous pulse loading of clomipramine in adolescents with depression. Psychopharmacol Bull. 1989; 25: 114–118.
18. Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C, Leischmann, R, Hill, C, Heninger, G, Charney, D. The Yale-Brown Obsessive- Compulsive Scale (Y-BOCS), part II: development, use, and reliability. Arch Gen Psychiatry. 1989; 46: 1006–1011.
19. Hamilton, M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6: 278–296.